Comparative Effect of Metformin versus Sulfonylureas with Dementia and Parkinson's Disease Risk in US patients over 50 with Type 2 Diabetes Mellitus

Newby D., Linden A., Fernandes M., Winchester L., Molero Y., Sproviero W., Ghose U., Li Q., Launer L., van dujn C., Nevado-holgado A.

DOI

10.1101/2022.07.08.22275837

Type

Preprint

Publication Date

09/07/2022

Permalink Original publication